Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$26.30 USD
+0.78 (3.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $26.28 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$26.30 USD
+0.78 (3.06%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $26.28 -0.02 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
Here's Why Momentum in Tourmaline Bio, Inc. (TRML) Should Keep going
by Zacks Equity Research
Tourmaline Bio, Inc. (TRML) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength
by Zacks Equity Research
Tourmaline Bio, Inc. (TRML) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
What Makes Tourmaline Bio, Inc. (TRML) a Good Fit for 'Trend Investing'
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Tourmaline Bio, Inc. (TRML) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.